Find a Tender
cancelled
Official procurement procedure
Drug Development Services
Medical analysis services
Paramedical services
Services provided by medical laboratories
Published value
Not published
Submission deadline Not published
Lots published7
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Cardiff University: "Drug Development Services". Published status: cancelled. Published value: Value not published. 7 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Cardiff University | Scope & Categories | Not published | Submission Window | cancelled No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Cardiff University
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Cardiff University. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 121 active published awards; 119 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityCardiff University | Procedure methodNot published | Procurement categoryNot published |
Statuscancelled | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Mar 2022, 12:53 GMT | Last source update9 Mar 2022, 12:53 GMT | Recurring procurementNot published |
ClassificationMedical analysis services, Paramedical services, Services provided by medical laboratories | ||
Delivery area | ||
OCIDocds-h6vhtk-02a63a | ||
What is being bought
Drug development Services
What changed
From the official release history
- Status changed to cancelled
9 Mar 2022, 12:53 GMT - Official notice release published
9 Mar 2022, 12:53 GMT - Submission deadline changed to published date
9 Mar 2022, 12:53 GMT - Status changed to active
15 Apr 2021, 11:15 BST - Official notice release published
15 Apr 2021, 11:15 BST - Submission deadline changed to 3 May 2021, 12:00 BST
15 Apr 2021, 11:15 BST - Buyer information updated
15 Apr 2021, 11:15 BST
Lots and requirements (7)
Published by the contracting authority
- Lot 1 · #1Electrophysiology ServicescancelledPublished valueNot publishedWe require providers for electrophysiology services relevant to neuroscience drug development.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2In-Vivo Rodent Behavioural AssayscancelledPublished valueNot publishedWe require providers committed to the principles of the NC3Rs for in-vivo behavioural assays.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3In-Vitro ADME-Tox servicescancelledPublished valueNot publishedWe require providers of ADME-Tox services as part of our drug development pipeline.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4In-Vivo Rodent ADME-ToxcancelledPublished valueNot publishedWe require providers committed to the principles of the NC3Rs for in-vivo ADME-Tox services.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #5In-Vivo ADME-Tox (Non-Rodent)cancelledPublished valueNot publishedWe require providers committed to the principles of the NC3Rs for in-vivo ADME-Tox services (not NHP).Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #6Manufacture of drug substance (API)cancelledPublished valueNot publishedWe require active substance manufacturers with GMP certification for API manufacture.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #7ChemistrycancelledPublished valueNot publishedWe require providers for chemistry services as part of our drug development pipeline.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
9 Mar 2022, 12:53 GMT - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published - Award unsuccessful
Not published · Not published
Commercial outcome and competition
Awards In-Vivo Rodent Behavioural Assays Not published · Not published · unsuccessful Electrophysiology Services Not published · Not published · unsuccessful In-Vitro ADME-Tox services Not published · Not published · unsuccessful In-Vivo Rodent ADME-Tox Not published · Not published · unsuccessful In-Vivo ADME-Tox (Non-Rodent) Not published · Not published · unsuccessful Manufacture of drug substance (API) Not published · Not published · unsuccessful Chemistry Not published · Not published · unsuccessful |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Cardiff University
Contracting authority GB-FTS-1902Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published